Predictive model for BNT162b2 vaccine response in cancer patients based on blood cytokines and growth factors.

While inflammatory marker CRP on its own did not emerge as a good classifier (see Supplementary Table 2 for more details) and did not correlate with anti-S or anti-RBD antibody titers measured as a continuous variable ( Figure 4A ), a highly significant difference was observed in CRP levels in good and poor responders at all studied timepoints ( Figure 4B ).

also in 132,142 other papers